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Abstract
Poly(lactic-co-glycolic acid) (PLGA) is one of the most commonly used copolymers for
electrospinning in tissue engineering applications. However, most research has not focused on
the copolymer itself in regards to how long it can be used effectively and if varying the
concentrations of polylactic acid (PLA) and polyglycolic acid (PGA) affect the resulting
properties. Electrospinning is the method we use to create the three-dimensional constructs,
or “scaffolds”, for the blood vessel mimic (BVM) in the tissue engineering lab. The aim of our
project was to investigate if the morphology and mechanical properties of the scaffolds changed
over time when they were stored in a dessicator. In addition, the morphology and properties from
75:25 and 85:15 PLGA copolymers were studied to determine whether there were significant
differences in fiber diameter, elastic modulus, or critical yield strength between them via
Scanning Electron Microscopy (SEM) image analysis and tensile testing of the samples. These
same three parameters were analyzed for the distal, medial, and proximal regions of the scaffold
for each concentration of PLGA. The main significant finding was that the regions of the
scaffold were relatively uniform in their properties. No timepoints were established, since there
was such large variation in the data and the trends were inconsistent. A larger and longer
duration study is needed to determine whether there is an ideal timeframe to use the scaffolds.
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I. Introduction
Cardiovascular Disease
Cardiovascular diseases are the biggest cause of death worldwide [23]. In the United
States alone, half a million people die of heart disease every year [23]. The most common
cardiovascular disease is atherosclerosis, or a condition in which an artery wall thickens due to
buildup of plaque. Plaque mainly consists of calcium, fibrous tissue, cholesterol, and fats.
Specifically, when low-density lipoproteins (LDLs) accumulate in the blood as a result of
deficient LDL receptors, this causes hypercholesterolemia. These LDLs are oxidized and are
accumulated by macrophages, which then become foam cells. As a part of this immune response,
cytokines are released that allow for the proliferation of smooth muscle cells into the intima of
the artery, causing intimal thickening or atheroma. Over time, this changes the properties and
physical appearance of the artery (Figure 1). The walls of the artery begin to harden and blood
flow is impeded as the condition worsens.

Figure 1: The progression of atherosclerosis from its early stages with increased plaque
buildup to more advanced stages that include proliferation of smooth muscle into the
intima, thickening of the vessel wall, and narrowing of the artery itself [1]
If exacerbated, this can cause thrombus formation and eventually lead to a myocardial infarction
(MI) or stroke if the thrombus breaks off and becomes an embolus. Both a MI and stroke will
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significantly shorten the lifespan of the individual, if it does not kill them in the process. Stroke
also happens to be the third most common cause of death in the U.S.; cancer is second [3].
In addition, there are a number of atherosclerotic-related diseases such as coronary heart
disease (CHD), carotid heart disease, peripheral artery disease, and chronic kidney disease, each
affecting a different region of the vasculature. For example, CHD occurs when there is plaque
build-up in the coronary arteries of the heart. Not surprisingly, it is also the most prominent
cause of death among men and women in the United States, accounting for approximately onethird of all deaths [2, 3]. If ischemia occurs in the region, then a common symptom will be
angina, or chest pain, which can be a warning sign for a potential MI. There are a number of risk
factors associated with atherosclerosis including lack of exercise, poor nutrition, smoking,
hypertension, diabetes, obesity, and a family history of heart disease [3].
Treatments
Current treatments for atherosclerosis include the use of drugs, surgical intervention, and
lifestyle changes. Often times, lifestyle changes such as eating healthy are the best treatment for
atherosclerosis [4]. Certain drugs, such as cholesterol medication, beta blockers, and calcium
channel blockers can slow the effects of atherosclerosis. As atherosclerosis becomes worse,
blockage of the artery can starve muscle and skin tissue of oxygen. At this point, a more
aggressive procedure is needed to restore blood to the tissue. Some of the more common
methods of surgical intervention are angioplasty and stent placement, endarterectomy, and
bypass surgery. Coronary artery bypass surgery is one of the most common surgeries performed
in the United States. Many advances in this surgery have lead to a minimally invasive method of
grafting the bypass tissue even while the heart is still beating [5]. With a more minimally
invasive surgery, recovery time and risk of infection decrease dramatically. The vessel graft in
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the place of the artery comes from a different place in the body, commonly the greater saphenous
veins. The graft vessel acts as a bypass so that blood can flow around the blockage (Figure 2).

Figure 2: The sites of plaque buildup are shown within the coronary arteries. The artery
bypass circumvents these occluded areas and allows blood to flow throughout the heart
unhindered [6]
Tissue Engineering
In an attempt to provide a more permanent solution, a newly emerging field in
biomedical engineering called tissue engineering offers promise for treating, and in certain cases,
curing cardiovascular disease. It has been defined as “an interdisciplinary field that applies the
principles of engineering and life sciences toward the development of biological substitutes that
restore, maintain, or improve tissue function or a whole organ" [7]. Using either biological or
artificial tissues, a construct or scaffold is created by various means including nanofiber selfassembly, solvent casting and particulate leaching, gas foaming, emulsification, or
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electrospinning, among others [8]. Cells are then “seeded” or implanted into the scaffold using a
bioreactor set-up; see Figure 3. The bioreactor provides a similar environment to the cells’
natural physiological environment, which allows them to grow and proliferate. The basic process
of creating tissue scaffolds from initial polymer processing and cell seeding to various
applications it can be used for is shown in Figure 4.

Figure 3: Bioreactor setup in the Cal Poly tissue engineering lab, including cell media
reservoir (left), peristaltic pump system (middle), and perfused scaffolds housed in the
bioreactors (right) [9]

Figure 4: Process for Creating Tissue-engineered Scaffolds [10]
There are many important features that a scaffold must have in order to allow for
maximal cell survival, which is usually measured in terms of confluency. These features include:
high porosity, adequate pore size, biodegradability, and strong mechanical properties similar to
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that of the native vessel or tissue. An advantage of using these artificially-grown tissues, vessels,
and organs is that there would be no risk of rejection, since the patient’s own cells would be used
to create it. It also limits the amount of cells that are needed by the patient. Cell lines can be
established by starting with a single cell line that can then grow and proliferate, with the correct
growth and differentiation factors added, to create new cell lines. This would also be a very
promising alternative to invasive surgeries, expensive grafts, and long waiting times for donor
organs.
Originally used for degradable sutures, poly lactic-co-glycolic acid (PLGA) has been
among the most attractive polymeric candidates used to fabricate devices for drug delivery and
tissue engineering applications [24]. It has a controllable degradation rate, based on the
compositions of PLA to PGA, and degrades via hydrolysis. The degradation products are not
harmful and are eventually removed from the body as carbon dioxide and water [16]. Since all
PLGAs are amorphous, the glass transition temperature and melting temperature are significantly
higher than other polymers, especially as the amount of PGA increases [17]. All these properties
of the copolymer are very important as they are most conducive to creating a vascular graft that
has a controllable degradation rate, is biocompatible and will not harm the host, and has a glass
transition temperature and melting temperature above normal body temperature. It also happens
to be very soluble and relatively easy to process based on research done previously in the Cal
Poly tissue engineering lab.
Electrospinning
The process of electrospinning will be looked at in more depth as it is the focus of our
research. The main reason why electrospinning is more attractive than some of the other tissue
engineering methods currently out there is it allows for the creation of non-woven polymeric
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fibers on the nanoscale level. This, in turn, creates a very large surface area-to-volume ratio,
which allows for maximum cell proliferation and attachment. The flexibility of the material
along with its mechanical properties are markedly improved compared to at the micrometer level
[11]. When cells are seeded into electrospun nanofibrous scaffolds, a greater quantity of
extracellular matrix is produced than those seeded on microfibrous scaffolds. High porosity,
improved mechanical properties, and morphological similarities to components of the native
extracellular matrix allow for a greater degree of cell adhesion, cell proliferation, and mechanical
integrity of the scaffold [12].Electrospinning seems to be one of the few processes that might
have mass production potential as well, especially with new advances in multi-jet
electrospinning and “blowing-assisted” electrospinning [13]. This is extremely important if
tissue engineering is to go beyond the research stages and into clinical applications.
Before electrospinning, there was electrospraying, which was first described by Sir
William Gilbert in the late 1500s. In his research, he observed how electrically charged amber
would form a cone shape when placed near water, which would then “spray” droplets of amber
from the tip of the cone. This cone shape was later named a “Taylor cone” after Sir Geoffrey
Ingram Taylor who mathematically modeled the shape of this cone as a result of the electric field
that was created [14]. Recent work has focused on using organic and synthetic polymers as the
feedstock, as it is typically called, for a range of applications including tissue engineering,
cosmetics, composite reinforcement, protective clothing, and electronics [15].
In order to create a scaffold through the process of electrospinning, the polymer must first
be dissolved in a solvent such as chloroform. It must then be charged using a high voltage power
supply (in the kV range) by attaching the positive electrode to the syringe that contains the
solution. A ground electrode attached to the collector system is needed to effectively allow the
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polymer to travel from the syringe to the mandrel attached to the collector. As the charge builds
up within the solution, the solution’s hemispherical shape begins to elongate forming the Taylor
cone at the tip of the syringe. Eventually, the normal effects of surface tension are overcome by
electrostatic repulsive forces. At this point, the fluid ejects from the tip of the syringe and begins
a complicated whipping instability pattern, which is pictured below in Figure 5. This whipping
pattern results from perturbations in the motion and trajectory of the fiber jet that overcome the
viscoelastic nature of the polymer [14,18]. This phenomenon is very important to the entire
process, however, as it allows most of the solvent to evaporate leaving behind just the polymer.
It also allows the fiber to further elongate and form a nanofibrous matrix on the mandrel. A
simplified setup of the electrospinning process is shown in Figure 6.

Figure 5: Diagram of the whipping instability that occurs during the ejection of the solution
from the syringe [19]
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Figure 6: Basic setup for electrospinning that includes the power supply, syringe, and
collector system [19]

There are a number of parameters to consider that will affect the resulting scaffold that is
created via the electrospinning process. These parameters include the voltage of the power
supply, gap distance between the mandrel and syringe, feedrate of the polymer, and both the
rotational and translational movement of the grounded mandrel. The magnitude of the voltage
supply is an important parameter because it controls the fiber diameter and fiber orientation of
the fibers in the scaffold. The voltage of the power supply determines the velocity of the polymer
jet. The higher the voltage, the faster the polymer travels and the less time the polymer has
before it is collected at the mandrel. This is called the flight time of the polymer [20]. Due the
behavior of the polymer inside the Taylor cone, higher voltages result in less flight time, which
allows for less elongation of the fiber and less whipping instability to occur. If the voltage is too
low compared to the extrusion rate, polymer will fall into the collecting tray. On the other hand,
if the voltage is too high, the fiber diameter will become inconsistent. This phenomenon is called
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“beading.” The gap distance between the syringe and the mandrel not only allows the solvent to
evaporate, but also plays a role in fiber orientation and diameter [11].
Previous Electrospinning Work
Although there has been a fair amount of research into how changing the various
parameters of the electrospinning setup can affect the scaffold properties, very little research has
focused on how time and different environments can affect these properties. Although relative
degradation rates are known for many of the synthetic polymers used in electrospinning research
[13], it would be worthwhile to determine a timeframe in which the scaffold itself is most viable
for cell attachment and growth. Since the scaffold is placed within a bioreactor setup after drying
within a dessicator and is subjected to fluid flow, the properties are bound to change compared to
when it is in a dry environment. In addition, the mechanical properties and fiber morphology
between different concentrations of PLGA has not been given much attention. The modulus for
different concentrations of PLGA has been documented, but in their unprocessed form [13].
Thus, mechanical properties after electrospinning have yet to be published and are bound to be
subject to the preparation of the solution and specific parameters used for the electrospinning
setup. It is important to find synthetic polymer that most closely resembles the native vasculature
in terms of its mechanical properties, hence why changing the concentrations of PLA and PGA
may be beneficial to achieve such properties.
Electrospinning work prior to this project has looked at setting up a working
electrospinner for in-house fabrication of our Blood Vessel Mimic (BVM) model by Colby
James [19], and the preparation and characterization of the electrospun PLGA scaffolds by
Tiffany Peña [25]. Additionally, the parameters for the current electrospinner were optimized by
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Deven Patel for the Blood Brain Barrier setup [26]. Achieving consistent fiber morphology that
is conducive to greater cell adhesion and proliferation is important to the overall goal of our lab.
Summary and Goals
The aim of our project is to investigate if the morphology and mechanical properties of
the scaffolds change over time when they are stored in the dessicator. If they do change with
time, then timepoints will need to be established to mark any significant changes. For example, if
there is a significant decrease in modulus after 14 days in the dessicator, then this can be
documented so that way others conducting blood vessel mimic (BVM) research know when to
use them by. This will ensure that their research stays consistent and is not affected by changes
in fiber morphology or mechanical properties. In addition, the morphology and mechanical
properties from 75:25 and 85:15 PLGA copolymers will be characterized and documented to
determine whether there are significant differences in fiber diameter, elastic modulus, or critical
yield strength among them. If consistent mechanical properties and fiber morphology are
exhibited by one of the other copolymer concentrations in terms of the application, then further
research may be warranted into their use in BVMs. These same parameters will be analyzed for
various regions of the scaffold to ensure properties are uniform throughout.
II. Methods
Polymer Mixing
A copolymer of Poly(lactic-co-glycolic acid), or PLGA, with separate compositions of
lactic acid and glycolic acid, were obtained from Sigma Aldrich (Milwaukee, WI). PLGA 85:15
has a composition of eighty-five percent lactic acid to fifteen percent glycolic acid, and PLGA
75:25 consist of seventy-five percent lactic acid with twenty-five percent glycolic acid. The
copolymer was dissolved in chloroform (CHCl3) to create a 15 wt% polymer (WPP) solution in
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accordance to the protocol specified in Appendix A1. Four vials of 75:25 and four vials of 85:15,
each with three milliliters of chloroform, were used. Polymer pellets were carefully weighed out
to 0.7835 grams and chloroform was measured out to 3 milliliters for each solution in order to
achieve consistent WPP solution, according to Appendix A1. An orbital mixing table was used to
mix the polymer solution for twenty-four hours. After the polymer mixed for twenty-four hours,
the solution was viable for forty-eight hours.
Electrospinning
Parameters used in the electrospinning process can be seen in Table 1 below.
Additionally, the settings of the electrospinning device were set to the following: translational
speed set to 3 (55 OPM), translational distance set to 16 cm, and rotational speed set to 6 (3110
RPM).

Table 1: List of parameters used for electrospinning
Voltage

-12000 Volts (negative polarity)

Flow Rate

5.5 mL/hr

Gap Distance

10 inches

Needle Size

18 gauge, beveled blunt (BD 305180)

*Note: Based on a previous study that we conducted in our lab, it was found that -12.5
kV was more ideal for 85:15 PLGA in terms of fiber consistency and properties, so this
voltage was used when electrospinning the 85:15 (See appendix A4 for a summary of this
study).
After mixing was completed and twenty-four hours passed, both solutions were
electrospun to create a total of eight scaffolds. Electrospinning was carried out according to the
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electrospinning protocol laid out by Deven Patel which was modified for this particular study
(Appendix A2). In order to allow the solvent to fully evaporate from the scaffold, all the
scaffolds were stored in the dessicator for twenty-four hours. After this latent period, scaffolds
were cut into sections for testing. Testing section dimensions can be seen in Figure 7. Scaffolds
were sectioned using a carbon steel blade into proximal, medial, and distal sections. These
sections were then cut into smaller half centimeter by one centimeter pieces for testing and
placed in multiple 12 well plates that were labeled with each test day, sample type, and sample
location.

Figure 7: Section dimensions (in centimeters) and labels for each scaffold. Dimensions are
repeated for medial and proximal regions (not shown). T signifies a tensile testing sample,
where S signifies a SEM sample
SEM Sample Preparation
In order to properly view the samples with the SEM, they had to be dehydrated first. The
dehydration protocol is as follows: 5 minutes in distilled H2O, 5 minutes in 25% EtOH, 5
minutes in 50% EtOH, 5 minutes in 70% EtOH, 5 minutes in 95% EtOH, 5 minutes in 100%
EtOH, 5 minutes in 100% EtOH. The samples were transferred into the labeled vials of EtOH
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with tweezers. Each sample was dehydrated in the same manner twenty-four prior to SEM
analysis. The samples were placed back into their respective well plates after dehydration.
SEM and Image Analysis
The inner lumen of each sample section was imaged at random locations at 500x
magnification using a Hitachi TM-1000 tabletop SEM. Only one image per sample was taken.
First, the specimen stage was pulled out of the SEM and placed in the specimen height gage. A
small piece of double-sided non-conducting tape was applied to the specimen stage to ensure the
samples would be held down properly. Each sample from a particular region was placed with
tweezers onto the stage, so that four samples would be imaged in a single set-up in the essence of
time. After the samples had been placed on the stage, the height gage was used to ensure there
was at least 1 mm of clearance, so that the samples would not be disturbed when inserting them
into the SEM. A laptop was hooked up the SEM, which had the proper software for the TM1000. By pressing the evacuation button on the SEM, the chamber was evacuated to allow for
clearer viewing of the sample. Each sample was carefully tracked by starting from the top of the
stage and imaging each sample going down using the translational knobs on the SEM. After
obtaining the correct magnification and focusing the image, the image was saved for later
analysis in ImageJ. The evacuation button was pressed again after viewing all the samples for a
certain region and a new sample set for another region was loaded onto the stage for imaging. A
single image was taken for each of the SEM samples after verifying that the image taken was
representative of the sample. Images taken did not include any edges of the sample since fiber
morphology would be more likely to be affected there from cutting the sample. This was
repeated for both concentrations over the course of the study. Fibers were measured using a
measuring macro in ImageJ. Line segments were manually moved onto the edges of each fiber.
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The line segments used for measuring showed the number of pixels in each line segment. By
measuring the fiber diameter and a given length bar at the bottom of the image, a value for the
fiber diameter was calculated. For each image, fibers were chosen at random from six circles
made on every image. Fiber diameter data is the average length of the six representative fibers.
Tensile Testing and Stress Strain Analysis
Samples of scaffold designated for tensile testing were tested at various timepoints in
order to represent the mechanical properties of the electrospun polymer over time. A testing
schedule was created and timepoints for data sampling were set every seven days. Tensile testing
samples were tested to failure using the Instron InSpec 2200 Tensile Testing Machine on
campus. A PalmPilot PDA was used as a data acquisition unit to record data in a time, extension,
and load format. The load was zeroed by pressing the “bal” button on the data acquisition unit
before testing each day to ensure a consistent baseline reading for the load. Initial dimensions of
samples were measured and recorded with calipers. The gauge length of the sample was
measured after the sample was placed in the tensile tester and clamped into place. The gauge
length of the sample is defined as the distance between the clamps of the tensile tester. Samples
were clamped into place using the hand screws on the test fixture. The extension was zeroed
before each sample test to eliminate a negative reading for the extension. This was done because
the macro we use cannot read data with negative extensions in the data set. Samples were pulled
in tension until a 0.5 N change in the load occurred. The tensile testing machine was switched to
its testing state which pulls samples at a consistent rate of 20 mm/min. Data output from the
Instron InSpec 2200 Tensile Tester was converted to data compatible with Microsoft Excel. By
modifying an existing macro in Visual Basic, given to us by Aubrey Dyer, stress versus strain
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curves were generated for all of our tensile testing samples. This macro is located in Appendix
A3.
Statistical Analysis
Two-sample t-tests were performed to compare sample concentrations, sample regions,
and samples that were tested on different days using Minitab 16 (2010). A p-value of 0.05 was
used for statistical significance. The timepoints that were compared were day 1, 7, 14, 21, and
28.
III. Results
SEM and Image Analysis
Following the protocol specified in the methods section, SEM images were taken for all
samples for each region and concentration for the particular day of testing. In order to expedite
the imaging process, the four samples from a particular region e.g. distal were all placed on the
specimen stage instead of imaging each sample one by one. All images were taken at 500x
magnification as specified in the methods section. Representative images for the two
concentrations, 75:25 and 85:15 PLGA, are shown below in figures 8 and 9.

Figure 8: Representative SEM image for
75:25 PLGA, taken from the distal region
on day 28 of testing

Figure 9: Representative SEM image for
85:15 PLGA, taken from the distal region
on day 28 of testing
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Important things to note about the images include the relative porosities, alignment of the
fibers, thickness of the fibers, and overall consistency of the fibers. After all images had been
taken for a particular day of testing, 6 fibers were analyzed in ImageJ for each image and an
average was taken. Average fiber diameters for the various regions of 75:25 and 85:15 PLGA
over the course of the study can be seen in figures 10 and 11, respectively.

Figure 10: Average fiber diameter for 75:25 PLGA for the distal, medial, and proximal regions of
the scaffold over the course of 28 days; n = 4
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Figure 11: Average fiber diameter for 85:15 PLGA for the distal, medial, and proximal regions of the
scaffold over the course of 28 days; n = 4

When performing two-sample t-tests in Minitab, no statistical differences were found
among the regions and the different days of testing for both concentrations in terms of fiber
diameter. Also, no visible trends can be seen for either figure 10 or 11.
Tensile Testing and Stress Strain Analysis
Tensile testing was performed as laid out in the methods section and stress-strain curves
were outputted using the macro found in appendix A3. Representative stress-strain curves for
75:25 and 85:15 PLGA are shown in figures 12 and 13 below.
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Figure 12: Representative stress‐strain curve for
75:25 PLGA, taken from the proximal region on
day 1 of testing

Figure 13: Representative stress‐strain curve for
85:15 PLGA, taken from the proximal region on
day 1 of testing

The linear portion of the stress-strain curve was also outputted simultaneously and the
equation of the line provided the elastic modulus of the sample. In Excel, the ultimate tensile
strength (UTS) was found from the maximum stress point along the curve and this was displayed
as well. Average elastic modulus for the various regions of 75:25 and 85:15 PLGA over the
course of the study can be seen in figures 14 and 15, respectively. Average UTS for the various
regions of 75:25 and 85:15 PLGA over the course of the study can be seen in figures 16 and 17,
respectively.
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Figure 14: Average elastic modulus for 75:25 PLGA for the distal, medial, and proximal
regions of the scaffold over the course of 28 days; n = 4

Figure 15: Average elastic modulus for 85:15 PLGA for the distal, medial, and proximal regions of the
scaffold over the course of 28 days; n = 4; *, p < 0.05 versus day 1
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When performing two-sample t-tests in Minitab, no statistical differences were found
among the regions and the different days of testing for 75:25 PLGA in terms of elastic modulus.
Also, no visible trend can be seen for figure 14. Conversely, for 85:15 PLGA, the modulus
decreased significantly in the medial region for days 14, 21, and 28 compared to day 1. Similar
trends can be seen for the distal and proximal regions when comparing days 14, 21, and 28 to
day 1 in figure 15.

Figure 16: Average ultimate tensile strength for 75:25 PLGA for the distal, medial, and proximal
regions of the scaffold over the course of 28 days; n = 4; *, p < 0.05 versus day 1
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Figure 17: Average ultimate tensile strength for 85:15 PLGA for the distal, medial, and proximal
regions of the scaffold over the course of 28 days; n = 4
When performing two-sample t-tests in Minitab, statistical differences were found in the
medial region for days 7, 14, 21, and 28 compared to day 1 for 75:25 PLGA in terms of UTS. An
increasing trend can be seen for all regions for 75:25 in figure 16. For 85:15 PLGA, there were
no statistical differences found among the regions and the different days of testing in terms of
UTS nor were there any major trends as can be seen in figure 17.
IV. Discussion
The goal of our project was to investigate if the morphology and mechanical properties of
the scaffolds change over time when they are stored in the dessicator, and to set time points to
note any statistically significant changes in fiber morphology and mechanical properties. In
addition, 75:25 and 85:15 PLGA copolymers were compared in terms of fiber diameter, elastic
modulus, and critical yield strength. These same three parameters were analyzed for the distal,
medial, and proximal regions of the scaffold for each concentration.
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In terms of fiber morphology, it seems that the 75:25 scaffolds have less overlapping fibers
and are more consistent overall. Further study must be done to quantify porosity. In terms of
fiber diameter, no significant differences were found among the regions of the scaffold for 75:25
or 85:15 PLGA, meaning that fiber diameter is relatively consistent along the length of the
scaffold. There were also no significant changes over the course of the study, which was
expected as long as moisture was removed from the scaffolds to prevent swelling in the
dessicator. It was expected that fiber diameter should be greater for 75:25 PLGA compared to
85:15 PLGA because PGA has a greater molecular weight than PLA. As the molecular weight of
the polymer or the polymer concentration is increased, so too does the solution viscosity. This, in
turn, causes the formation of larger diameter fibers which lend improved mechanical properties,
especially tensile strength to the scaffold [22]. However, this was not the case as no significant
differences existed between the concentrations in terms of fiber diameter; in fact, 85:15 PLGA
was slightly higher on average. This may be attributed to the fact that a slightly higher voltage
was used (12.5 kV instead of 12.0 kV) when electrospinning the 85:15 scaffolds, which would
then produce smaller diameter fibers than expected.
In terms of elastic modulus, a significant decrease in modulus was noted after day 7 for
85:15 PLGA but not for 75:25. There were significant differences between the concentrations
after day 7 as well, since the modulus for 85:15 dropped dramatically. There were no differences
among the regions of the scaffold for either concentration. In terms of UTS, there was a
significant increase after day 1 for 75:25 but not for 85:15. Once again, there were no differences
among the regions of the scaffold for either concentration nor were there significant differences
between the concentrations. Modulus and yield strength were expected to be higher for the 75:25
samples because the crystallinity of PGA is higher than for PLA. As crystallinity increases, the
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mechanical and thermal properties of the polymer such as strength tend to increase [21]. This
theory seems to be true for modulus, which was significantly higher for 75:25 but may not
necessarily be true for UTS. Although, UTS did steadily increase for 75:25 over the course of the
study while it remained relatively level for 85:15, meaning that if the study was carried out
longer, significant differences may have been found between the two concentrations in terms of
UTS.
When comparing the values of the Elastic Modulus, UTS, and fiber diameter of this study
to Tiffany Peña, the majority of the results from both studies are very similar, besides elastic
modulus. Table 2 below compares the results of this study and Tiffany’s.
Table 2: Comparison between Studies

Tiffany
Sean/Nick

Elastic Modulus
(MPa)
39.4

UTS (MPa)

Fiber Diameter (μm)

4.29

5.49

19.45

3.46

6.97

It is important to note the difference in parameters used to electrospin when comparing results
for the two studies. The first is the orientation of the sample. Both of the studies tested samples
in a circumferential orientation. Both studies also used a flow rate of 5.5 mL per hour. The
parameter that was changed between the two studies was the applied voltage. This study used a
slightly higher voltage of 12.5 kV as compared to 12 kV in Tiffany’s study. However, it is
unlikely that this small change in voltage would be enough to cause such a great change in the
elastic modulus. It is more likely the difference in cutting procedures for the scaffolds that
induced such a great change. This will be discussed more in the next section. Additionally, with
a larger sample size used in this study, mandrels needed to be modified to allow for higher

24

throughput. Specifically, a special attachment was used on some of the newly created mandrels,
which is pictured in figure 18 below.

Figure 18: Attachment for the mandrel to fit into the collector system properly (pictured on the left
side of the mandrel)
It is possible that this attachment may have skewed some of the results in terms of how the fibers
aligned and may have stretched the scaffold when removing it from the mandrel, but from our
previous study (Appendix A4) it seems that the data we are getting is still consistent and not
significantly affected by this attachment.
V. Limitations
Our current procedure includes sectioning the scaffold by cutting it with a razor blade. This
method causes slight variations in the fiber morphology at the edges of samples and can create
stress concentrations in the sample. These stress concentrations may cause variations in the
sample’s mechanical properties. With our current tensile testing fixture, this is unavoidable.
Samples must be cut into strips so that they can be loaded into the tensile tester. Furthermore,
variations in tensile testing technique will yield inconsistent results. Loading samples into the
tensile tester changed the overall shape of the sample, which may cause changes in the fibers.
We notice that by flattening the samples when placing them into the test fixtures, a crease
formed in the sample. Failure in the samples consistently occurred along this crease. This crease
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may have caused premature failure in our samples. Additionally, during the later testing days,
samples became more difficult to load into the tensile tester. For the first fourteen days of SEM
testing, the SEM was not properly calibrated, producing low quality images that made fiber
analysis very difficult in ImageJ.
VI. Future Work
Future iterations of this study should use a different test fixture. To avoid variations in
data, the scaffold itself should be intact. There is an existing test fixture that would allow testing
of tubular samples. By not deforming a sample through sectioning, more consistent and accurate
data can be obtained. Further work in electrospinning should include a study to optimize
electrospinning parameters for the 85:15 PLGA concentration. To further characterize the
scaffold, porosity should be quantified for each scaffold. This is one of the more important
properties of scaffolds that influence cell seeding and adhesion.
VII. Conclusions
From our study, it can be concluded that mechanical properties and fiber morphology do
not change along the scaffold length, at least in terms of the parameters tested. 75:25 PLGA
seems to be a better concentration to use for BVM studies based on SEM images taken and
slightly improved mechanical properties exhibited, although this is merely based on trends. A
longer and larger study would be needed to validate this claim. Lastly, although there were no
major changes in scaffold properties that would deem them to be “unusable” over the course of
this study, we still recommend using the PLGA scaffolds within two weeks as noted by
significant changes in mechanical properties at day 14 for both concentrations.
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IX. Appendix
A1: Mixing PLGA Solutions
*Note: Protocol used comes from Tiffany R. Pena’s thesis.

Table 1: Bill of Materials
Materials/Equipment
Poly (DL-lactide-co-glycolide) (PLGA)
Lactide: Glycolide (75:25)
Mol wt 66,000 - 107,000
Chloroform, extra dry, water <50ppm,
stabilized
10 ml Syringe, Luer-Lok tip
Blunt Fill Needle, 18G 1 ⅟2 (1.2 mm x
40 mm)
Analytical Balance
Orbital Shaker [check new shaker]
Vacuum-Pressure Pipette Aid
Serological Pipet 5 x 1/10 ml
Clear Glass Vial 20 ml

Vendor
Sigma-Aldrich

Part Number Quantity
P1941
5 grams

Fisher Scientific, Inc

326820010

1 Liter

309604
305180

100/Pack
100/Pack

Acculab

ALC-80.4

Drummon Scientific Co.
VWR International
VWR International

P-80991
53283-706
15900-002

1
1
1
NA
72/CS

BD
BD

Procedure
1. Calculate the amount of PLGA resin necessary for the desired weight percent polymer solution
using the following equation. (Density of chloroform is 1.48 g/ml.)
WPP = m1/ (m1 + m2b)
*WPP = Weight percent polymer solution
m1 = mass of polymer (g)
m2 = mass of solvent (ml)
b = density of solvent (g/ml)
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**
*Always use 0.15 for WPP
**Mass of polymer for a 3mm scaffold
Note: For 4mm scaffold, use 1.0447 g.
2. Put on safety gloves. (WARNING: Chloroform can have serious sideeffects if it comes in contact with skin, eyes or is inhaled or swallowed.
Target organs to be effected are kidneys, heart, central nervous system,
liver, eyes, reproductive system and skin. Always open chloroform in a
hood and wear protective clothing!!

Figure 2: Bottled
PLGA

3. Remove PLGA (Figure 2) from the freezer and allow it to reach room
temperature (5-10 minutes). Doing so prevents condensation when the polymer is
exposed to air.
4. Weigh out the calculated amount of PLGA using the Acculab Balance (Error!

Reference source not found.) and place the polymer in a 20 ml clear vial. Close

Figure 3: Acculab
Balance

the lid immediately.
5. Return unused PLGA to the freezer.
6. Retrieve the chloroform (Figure 4) for the hazardous chemical cabinet and
place it in the fume hood immediately.
7. Gather the Pipette-Aid, a 10 ml disposable pipette and the vial of weighed
PLGA and place in the hood with the chloroform.
8. Pipette the desired volume of chloroform into the vial with PLGA.
Immediately cap the vial as well as the chloroform container to prevent
evaporation of chloroform since it is highly volatile.

Figure 4: Bottled
chloroform
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9. Properly label the solution vial with the WPP, date and your initials (Figure 5).
10. Wrap vial in aluminum foil to prevent light from entering the solution
(chloroform is highly sensitive to light).
11. Place the vial on the shake table. Set the shake table to approximately 3
revolutions per second. Use tape to ensure that the vial will stay upright while on

Figure 5: Labeled
vial of WPP

the shake table. Turn the table on.
12. Allow the solution to mix for 24 hours. After mixing is complete, the solution is usable for up to
48 hours.
13. Remove chloroform container from hood and place back into chemical cabinet.
14. Properly dispose of the pipette tip.
15. Clean up work area.
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A2: Electrospinning Protocol
*Protocol is a modified version of Deven Patel’s protocol for electrospinning.

WARNING: This process utilizes extremely high voltages. Always wear shoes, gloves, and be careful of
what you are contacting. To use the electrospinner, you must be trained by a qualified user and be
approved by an appropriate faculty member.

Polymer:
Flow Rate:
Needle:
Gap:
Voltage:
Translate:
Rotate:

15wt% PLGA in Chloroform (CHCl3)
5.5ml/hr, 3ml of polymer solution used
18 gauge, beveled, blunt (BD 305180)
10 inches
‐ 12,500V (negative polarity)
Distance set at 10 in., translation speed set at 3 or 55 OPM
Rotation speed at 6 or 3110 RPM
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1) Put on latex gloves.
2) Clean debris left from previous spins using paper towels and
isopropal alcohol (IPA). Be sure to clean polymer collection
system (Figure 1) and inside walls of the isolation chamber.

Figure 1: Clean collection system

3) Sand mandrel with 1200 grain sandpaper (Figure 2), then
spray and clean off with IPA. Be sure that the mandrel is clean
before using it.
4) Insert mandrel into collector.
5) Attach an 18 gauge BD needle to a BD 10ml plastic syringe.
6) Inside the fume hood, pull the desired amount of polymer

Figure 2: Sand mandrel with sand
paper

solution into the syringe. The polymer solution is very
viscous, so this will take some time. Be sure that there is no
air within the syringe. Use a wipe to purge the air from the
syringe.
7) Place needle through the small hole drilled in the isolation
chamber and set the syringe onto the syringe pump (Figure

Figure 3: Secure syringe on syringe
pump, and place needle into the
isolation chamber

3).
8) Secure the syringe into position using the black clamp on the
syringe pump.
9) Clip the red high voltage alligator clip to the needle inside the
isolation chamber, see Figure 4.
10) Position the collection system in the isolation chamber so
Figure 4: Attach high voltage alligator
clip to needle.
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that the metal mandrel and needle tip are at the desired gap distance and perpendicular to each
other
11) Take the black ground banana plug and connect to the collector
system as seen in Figure 5.
12) Using a multimeter, check the resistance between the ground
connection and the aluminum mandrel to verify conductivity. One
should see very little resistance (fractions of an ohm) if the mandrel
is properly grounded. If a very high resistance is detected, the

Figure 5: Connect black ground wire to
collection system.

mandrel is no longer maintaining continuity with the ground wire.
13) Close the front panel of the isolation chamber.
14) Next, plug in the surge protector into the wall outlet of the fume hood.
15) Flip the green switch on the surge protector to turn it on, and as a result provide power to the
syringe pump, rotation and translation regulator, and power supply.
16) Switch on the syringe pump, and enter the desired settings (syringe type, volume, flow rate, etc.).
The syringe pump will maintain the same settings that were used previously. So if no one has used
the apparatus since, there is no need to make any changes to the syringe pump programming.
Syringe Type: BD 10 ml Plastic syringe (select from syringe pump library)
Volume: 3 mL
Flow Rate:5.5 ml/hr

17) Turn on the "Rotate" and "Slide" functions of the collector at
the regulator box. The speed at which the mandrel rotates
and translates is controlled from this box. Settings 3 for
translation, and 6 for rotate.

Figure 6: High Voltage Power supply.

18) Press the "Run" button on the syringe pump so that the
polymer solution will begin ejecting at a controlled volumetric rate.
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19) Once a polymer droplet forms at the tip of the spinneret, the electrospinning process is ready to
start. Immediately turn on the power supply (Figure 6 ), press red button, and adjust output voltage
knob to the desired applied voltage.
20) Observe the process of the entire spin, slowly the metal
mandrel will become visibly coated with polymer (white color).
21) Once the desired amount of polymer solution has been
electrospun, the process should be shut down in the following
manner.

Figure 7: Detach polymer coated mandrel
from collection system

22) Turn the high voltage power supply off, by flipping the red switch to "off."
23) Next, press the "Run/Stop" button on the syringe pump to stop the pump. Then turn the syringe
pump off.
24) Turn the "Rotate" and "slide" switches off on the regulator box.
25) Flip the green switch of the surge protector to "off." And then unplug the surge protector from the
wall outlet of the fume hood.
26) Slide open the front panel of the isolation chamber and wait for a few minutes to allow the
evaporated solvent to leak out and be taken up by the fume
hood.
27) Detach the polymer coated mandrel from the collector
system, see Figure 7.
28) Contact the red high voltage alligator clip to the black
ground wire to remove any residual charge.
29) Clean any polymer fiber debris using paper towels and
isopropal alcohol (IPA). Be sure to clean polymer collection
system (Figure 1) and inside walls of the isolation chamber.

Figure 8: Dispose any material that
came in contact with chloroform into
Hazardous Waste bucket.
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30) Dispose of the syringe needle in the sharps container.
31) Dispose syringe and polymer solution vials into Hazardous Waste
bucket, Figure 8.
32) Take the polymer coated mandrel to the desiccator and leave for at
least 24 hours before sectioning, Figure 9.
33) Cut polymer scaffold off of metal mandrel between 24‐48 hours later
(once polymer is completely dry) and place onto glass rod in
desiccator; be sure rod is labeled clearly (with tape).
34) Return metal mandrel to top of desiccator box.

Figure 9: Place metal mandrel
with polymer scaffold around
it into the desiccator after
electrospinning.
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A3: Visual Basic Macro
*Note: Macro provided by Aubrey Dyer; later modified for our own study
Sub TensileTestMacro()
'December 12, 2012'
Dim Filename()
Close #1
k=0
d = InputBox("How many tests would you like to analyze?")
If d > 3 Then
For k = 4 To d
'you didn't type in a number'
Worksheets.Add
Next
End If
For j = 1 To d
m=0
Max = 0
sumofx = 0
sumofy = 0
sumofxy = 0
sumofxx = 0
sumofxsquared = 0
Delta = 0
a=0
b=0
c=0
l=0
' Filename = InputBox("Enter the file", , "85_15_#1_d.csv")
' Pathname = InputBox("Enter the path to " + Filename, , "C:\Users\Public\Documents\Electrospinning\")
Call FileDialogOpen(Filename())
myfile = Filename(j)
Name = InputBox("What test is this?")
a = InputBox("What is the gauge of the sample?")
b = InputBox("What is the width of the sample?")
c = InputBox("What is the thickness of the sample?")
Worksheets(j).Name = Name
'you kept hitting cancel didn't you?'
Worksheets(Name).Cells(1, 1).Value = "Time"
Worksheets(Name).Cells(1, 2).Value = "Extension"
Worksheets(Name).Cells(1, 3).Value = "Load"
Worksheets(Name).Cells(1, 4).Value = "Strain"
Worksheets(Name).Cells(1, 5).Value = "Stress"
Worksheets(Name).Cells(1, 7).Value = "Linear Strain"
Worksheets(Name).Cells(1, 8).Value = "Linear Stress"
Worksheets(Name).Cells(1, 10).Value = "Critical/Yield Stress"
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Worksheets(Name).Cells(1, 11).Value = "20% Yield Stress"
Worksheets(Name).Cells(1, 12).Value = "50% Yield Stress"
Worksheets(Name).Cells(1, 13).Value = "Slope"
Worksheets(Name).Cells(1, 14).Value = "y-intercept"
Open myfile For Input As #j 'Typed the filename wrong/file doesn't exist/you've already opened it
this session'
i=0
Do Until EOF(j)
Input #j, tm, x, y
If i = 0 Ori = 1 Then
Worksheets(Name).Cells(i + 2, 1).Value = tm
Worksheets(Name).Cells(i + 2, 2).Value = x
Worksheets(Name).Cells(i + 2, 3).Value = y
i=1+i
Else
If (x >= 0) And (y > 0) Then
i=i+1
Worksheets(Name).Cells(i - 1, 1).Value = i - 2
'need to delete the
Worksheets(Name).Cells(i - 1, 2).Value = x
'first two lines of
Worksheets(Name).Cells(i - 1, 3).Value = y
'the notepad file
Worksheets(Name).Cells(i - 1, 4).Value = x / a
'(only data points
Worksheets(Name).Cells(i - 1, 5).Value = y / (b * c)
'no words) or you messed up typing a value into
the size of the sample
t=x/a
u = y / (b * c)
If u > Max Then
Max = u
timestop = (i - 2)
End If
Worksheets(Name).Cells(2, 10).Value = Max
e = (0.2) * Max
f = (0.5) * Max
Worksheets(Name).Cells(2, 11).Value = e
Worksheets(Name).Cells(2, 12).Value = f
End If
End If
Loop
g=0
r=0
p=1
For m = 1 To (i - 2)
g=g+1
o = Worksheets(Name).Cells(g, 1).Value
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h = Worksheets(Name).Cells(g, 5).Value
n = Worksheets(Name).Cells(g, 4).Value
If h >= e And h <= f And o <= timestop Then
p=p+1
Worksheets(Name).Select
Cells(g, 4).Select
Selection.Font.Bold = True
Cells(g, 5).Select
Selection.Font.Bold = True
Worksheets(Name).Cells(p, 7).Value = n
Worksheets(Name).Cells(p, 8).Value = h
End If
Next
Worksheets(Name).Cells(8, 1).Select
Charts.Add
With ActiveChart
.ChartType = xlXYScatterSmoothNoMarkers
.SetSourceData Source:=Sheets(Name).Range("D:E"), PlotBy:=xlColumns
.Location Where:=xlLocationAsObject, Name:=Name
End With
With ActiveChart
.HasTitle = True
.ChartTitle.Text = "Stress-Strain Curve"
.Axes(xlCategory, xlPrimary).HasTitle = True
.Axes(xlCategory, xlPrimary).AxisTitle.Characters.Text = "Strain"
.Axes(xlValue, xlPrimary).HasTitle = True
.Axes(xlValue, xlPrimary).AxisTitle.Characters.Text = "Stress"
.HasLegend = False
End With
Worksheets(Name).Cells(16, 6).Select
q=p-1
Charts.Add
With ActiveChart
.ChartType = xlXYScatter
.SetSourceData Source:=Sheets(Name).Range("G:H"), PlotBy:=xlColumns
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.Location Where:=xlLocationAsObject, Name:=Name
End With
With ActiveChart
.HasTitle = True
.ChartTitle.Text = "Linear Stress"
.Axes(xlCategory, xlPrimary).HasTitle = True
.Axes(xlCategory, xlPrimary).AxisTitle.Characters.Text = "Strain"
.Axes(xlValue, xlPrimary).HasTitle = True
.Axes(xlValue, xlPrimary).AxisTitle.Characters.Text = "Stress"
.HasLegend = False
End With
ActiveChart.SeriesCollection(1).Select
'ActiveChart.SeriesCollection(1).Points(q).Select
ActiveChart.SeriesCollection(1).Trendlines.Add(Type:=xlLinear, Forward:=0, _
Backward:=0, DisplayEquation:=True, DisplayRSquared:=True).Select
Close #j
Next
End Sub

Sub FileDialogOpen(Filename())
Dim lngCount As Long ' allow for multiple file selection (Completely Optional!)
' Open the file dialog
With Application.FileDialog(msoFileDialogOpen)
.AllowMultiSelect = True 'This code is multiple file
.Show
n = .SelectedItems.Count
ReDimFilename(n)
' Display paths of each file selected
For lngCount = 1 To n
Filename(lngCount) = .SelectedItems(lngCount)
Next lngCount
End With
End Sub
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A4: Previous Study of 50:50 and 85:15 PLGA
Objective:
To determine if varying the concentrations of PLA and PGA that make up the copolymer
PLGA affect the resulting fiber characteristics and mechanical properties. In addition, the effect
of the local environment will be investigated in terms of if the properties change in a “wet” vs.
“dry” environment.
Methods:
The two concentrations that were tested were 50:50 and 85:15 PLGA. Four scaffolds of
the 50:50 and four scaffolds of the 85:15 were electrospun using a flow rate of 5.5 ml/hr and a
voltage of 13.5 kV. All eight scaffolds were spun on the same day. In order to accomplish this,
six mandrels had to be created that were 0.118 inches in diameter instead of the usual 0.125
inches. The two pre-made mandrels that were readily available had a diameter of 0.125 inches.
After a 24-hour waiting period, each of the scaffolds was sectioned so that each 1 cm sample
would be used for tensile testing and each 0.5 cm sample would be used for SEM image analysis.
The samples were separated into 6-well plates and each well was labeled according to the test
day, the type of test, concentration of the copolymer, and whether the sample was soaked in
Medium 199 or not (“wet” vs. “dry”). The samples that were soaked in the media were placed in
the fridge in centrifuge tubes until the day of testing. Testing was done every 7 days, starting
with day 1 which occurred 24 hours after sectioning the samples. Day 1, 7, and 14 had wet and
dry sample testing, while day 21 and 28 only had dry testing. For SEM analysis, the samples had
to be dehydrated one day prior to testing. For each day of testing, three tests were conducted for
each concentration to allow for statistical analysis and comparison of the data later on.
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Results:
SEM images were taken for all wet and dry samples for both concentrations on the
particular day of testing. All images were taken at 500x magnification as specified in the
methods section. Representative images for the two concentrations, 50:50 and 85:15 PLGA, are
shown below in figures 1 and 2, for wet and dry samples respectively.

Figure 1: Representative SEM images for 85:15 and 50:50 PLGA wet samples over the
course of 14 days

43

Figure 2: Representative SEM images for 85:15 and 50:50 PLGA dry samples over the
course of 14 days
Important things to note about the images include the relative porosities, alignment of the
fibers, thickness of the fibers, and overall consistency of the fibers. After all images had been
taken for a particular day of testing, 6 fibers were analyzed in ImageJ for each image and an
average was taken. A comparison of average fiber diameters of wet and dry samples for 85:15
PLGA over the course of 14 days can be seen in figure 3, in which dry samples were
significantly different from wet samples.

44

Figure 3: Wet and dry samples of 85:15 PLGA in terms of average fiber diameter over the
course of 14 days; n = 3; *, p < 0.05
The average fiber diameters from different days of testing were also compared to day 1 to
distinguish if there were any trends. Figure 4 shows this progression for wet samples while figure
5 shows the same for dry samples. There was only a significant difference at day 14 for wet
samples. After day 1, the fiber diameter continued to change significantly for dry samples.
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Figure 4: Wet samples of 85:15 PLGA in terms of average fiber diameter over the course of
14 days; n = 3; *, p < 0.05 versus day 7

Figure 5: Dry samples of 85:15 PLGA in terms of average fiber diameter over the course of
28 days; n = 3; *, p < 0.05 versus day 1; **, p < 0.05 versus day 7; +, p < 0.05 versus day 1
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Tensile testing was performed and stress-strain curves were outputted using the macro
found in appendix A3. Representative stress-strain curves for 85:15 PLGA dry samples are
shown in figure 6. A side-by-side comparison of both wet and dry stress-strain curves for 85:15
PLGA is shown in figure 7.

Figure 6: Representative stress-strain curves for 85:15 PLGA dry samples over the course
of the study

Figure 7: Representative stress-strain curves for 85:15 PLGA wet and dry samples
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The linear portion of the stress-strain curve was also outputted simultaneously and the
equation of the line provided the elastic modulus of the sample. In Excel, the ultimate tensile
strength (UTS) was found from the maximum stress point along the curve and this was displayed
as well. Average elastic modulus for 85:15 PLGA wet and dry samples over the course of the
study can be seen in figure 8. Average UTS for 85:15 PLGA wet and dry samples over the
course of the study can be seen in figure 9. No significant differences were found in terms of
elastic modulus, but there were significant differences for UTS after day 7 of testing.

Figure 8: Wet and dry samples of 85:15 PLGA in terms of average elastic modulus over the
course of 28 days; n = 3
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Figure 9: Wet and dry samples of 85:15 PLGA in terms of average critical yield strength
over the course of 28 days; n = 3; *, p < 0.05 versus day 1; #, p < 0.05 versus day 7; ** p <
0.05 versus day 14 wet
Discussion:
The objective of this study was to determine if varying the concentrations of PLA and PGA
that make up the copolymer PLGA affect the resulting fiber characteristics and mechanical
properties, in which 50:50 and 85:15 PLGA were compared. In addition, the effect of the local
environment was investigated in terms of if the properties change in a “wet” vs. “dry”
environment by placing some of the samples in media and allowing them to soak before testing.
It cannot necessarily be stated that there is a definite increase or decrease in fiber diameter
with time or between wet and dry samples, despite the statistical differences seen in figures 3, 4
and 5. The confidence level may actually be too high for such measurements and a smaller pvalue may be needed to truly tell whether significant differences exist in this data. The stressstrain curves for the wet and dry samples are fairly similar, although the time to failure, in which
plastic deformation is occurring, seems to be much greater for the wet samples. During the data
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collection for tensile testing, we noticed that the 50:50 samples tore pre-maturely near the clamps
and had very low yield strength compared to the 85:15 samples. Once we looked at the 50:50
samples under the SEM, we noticed beading had occurred in some of the samples instead of the
more elongated fibers that are obviously more ideal. This beading led to very poor mechanical
properties (modulus and yield strength) and would not be suitable as constructs for BVMs. This
inconsistency in fiber diameter leads us to believe that the original parameters i.e. voltage and
flow rate are not ideal for the 50:50 co-polymer and that further experimentation into optimizing
these two parameters must be conducted in order to achieve consistent fibers as seen in the 85:15
samples.

